Could a pill designed for blood sugar control help rebuild the human jaw?That’s one of the questions driving Abraham Schneider, DDS, PhD, associate professor and chair of the Department of Oncology and Diagnostic Sciences at the University of Maryland School of Dentistry. With support from the National Institutes of Health, Schneider is studying how metformin, a widely used and affordable drug for type 2 diabetes, might also help regenerate craniofacial bone — offering a new, cost-effective strategy to treat damage caused by trauma or disease.“We are trying to regenerate a craniofacial bone that is affected by several conditions, including periodontal disease and trauma,” Schneider said. “So, we are trying to look for new ways of regenerating bone.”#OralCancer #DentalResearch #BreakthroughsCantWait #NIHResearch #HeadNeckCancer #CraniofacialBiology #CancerTreatment #UniversityOfMaryland #MedicalBreakthroughs

What if we could regenerate bone using a medication already on the market?At the University of Maryland, Baltimore, researchers are exploring how metformin — a drug commonly used to treat diabetes — could be repurposed to stimulate bone growth and healing.This is just one of many NIH-funded breakthroughs at UMB with the power to transform medicine and save lives.🧪 Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.🔗 Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs#BreakthroughsCantWait #BoneRegeneration #MetforminResearch #DiabetesDrugInnovation #MedicalBreakthroughs #UMBResearch #NIHfunding #TissueEngineering